Sage Journals: Discover world-class research

Abstract

The world’s first accelerator based epithermal neutron source for clinical boron neutron capture therapy (BNCT) was designed, developed, and commissioned between 2008 and 2010 by Sumitomo Heavy Industries in collaboration with Kyoto University at the Kyoto University Institute for Integrated Radiation and Nuclear Science. The accelerator system is cyclotron-based and accelerates a proton up to an energy of approximately 30 MeV. The proton strikes a beryllium target, which produces fast neutrons that traverse a beam shaping assembly composed of a combination of lead, iron, aluminum, and calcium fluoride to reduce the neutron energy down to the epithermal range (∼10 keV) suitable for BNCT. The system is designed to produce an epithermal neutron flux of up to $1.4 \times 10^{9} n \cdot {cm}^{- 2} \cdot s^{- 1}$ (exiting from the moderator of a 12 cm diameter collimator) with a proton current of 1 mA.

In 2017, the same type of accelerator was installed at the Kansai BNCT Medical Center and in March 2020 the system received medical device approval in Japan (Sumitomo Heavy Industries, NeuCure^® BNCT system). Soon after, BNCT for unresectable, locally advanced, and recurrent carcinoma of the head and neck region was approved by the Japanese government for reimbursement covered by the national health insurance system.

Keywords

BNCT Cyclotron neutron detection Monte Carlo simulation commissioning

Get full access to this article

View all access options for this article.

References

Coderre

J.A.

et al., Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9l rat gliosarcoma in vitro and in vivo, Int. J. Radiat. Oncol. Biol. Phys.27(5) (1993), 1121–1129. doi:10.1016/0360-3016(93)90533-2.

Coderre

J.A.

et al., Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity, Radiat. Res.149(2) (1998), 163–170, [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/9457896. doi:10.2307/3579926.

Coderre

J.A.

Morris

G.M.

Micca

P.L.

Fisher

C.D.

and Ross

G.A.

, Comparative assessment of single-dose and fractionated boron neutron capture therapy, Radiat. Res.144(3) (1995), 310–317, [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/7494875. doi:10.2307/3578951.

Fukuda

et al., Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor, Australas. Phys. Eng. Sci. Med.26(3) (2003), 97–103. doi:10.1007/BF03178777.

et al., Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system, Radiat. Oncol.16(1) (2021), 1–13. doi:10.1186/s13014-021-01968-2.

International Atomic Energy Agency, Current Status of Neutron Capture Therapy, no. 1223. Vienna: IAEA-TECDOC-1223, 2001.

Jednoróg

Scholz

Paduch

Bienkowska

and Szydłowski

, Preliminary determination of angular distribution of neutrons emitted from PF-1000 facility by indium activation, Nukleonika57(4) (2012), 563–568.

Kawabata

et al., Accelerator-based BNCT for patients with recurrent glioblastoma: A multicenter phase II study, Neuro-Oncology Adv.3(1) (2021), 1–9. doi:10.1093/noajnl/vdab067.

Kiyanagi

Sakurai

Kumada

and Tanaka

, Status of accelerator-based BNCT projects worldwide, AIP Conf. Proc.2160 (2019). doi:10.1063/1.5127704.

10.

Kreiner

A.J.

et al., Present status of accelerator-based BNCT, Reports Pract. Oncol. Radiother.21(2) (2016), 95–101. doi:10.1016/j.rpor.2014.11.004.

11.

Mitsumoto

et al., Cyclotron-based neutron source for BNCT, AIP Conf. Proc.1525 (2013), 319–322. doi:10.1063/1.4802341.

12.

Nichols

T.L.

Miller

L.F.

and Kabalka

G.W.

, The microdosimetry of boron neutron capture therapy in a randomised ellipsoidal cell geometry, Radiat. Prot. Dosimetry116(1–4) (2005), 466–469. doi:10.1093/rpd/nci248.

13.

Sakurai

and Kobayashi

, Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra, Nucl. Instruments Methods Phys. Res. Sect. A Accel. Spectrometers, Detect. Assoc. Equip.453(3) (2000), 569–596. doi:10.1016/S0168-9002(00)00465-4.

14.

Sato

et al., Features of particle and heavy ion transport code system (PHITS) version 3.02, J. Nucl. Sci. Technol.55(6) (2018), 684–690. doi:10.1080/00223131.2017.1419890.

15.

Tanaka

et al., Experimental verification of beam characteristics for cyclotron-based epithermal neutron source (C-BENS), Appl. Radiat. Isot.69(12) (2011), 1642–1645. doi:10.1016/j.apradiso.2011.03.020.

16.

Yanch

J.C.

Zhou

X.-L.

and Brownell

G.L.

, A Monte Carlo investigation of the dosimetric properties of monoenergetic neutron beams for neutron capture therapy, Radiat. Res.126(1) (1991), 1–20. doi:10.2307/3578165.

Accelerator based epithermal neutron source for clinical boron neutron capture therapy

Abstract

Keywords

Get full access to this article

References